Treatment with leuprolide acetate and hormonal add-back for up to 10 years in stage IV endometriosis patients with chronic pelvic pain
Open Access
- 31 July 2006
- journal article
- clinical trial
- Published by Elsevier BV in Fertility and Sterility
- Vol. 86 (1), 220-222
- https://doi.org/10.1016/j.fertnstert.2005.12.030
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Prevention of bone loss and hypoestrogenic symptoms by estrogen and interrupted progestogen add-back in long-term GnRH-agonist down-regulated patients with endometriosis and premenstrual syndromeMenopause, 2002
- The Effect of Androstenedione/Estrone Supplementation on Cortical and Cancellous Bone in the Young Intact Female Monkey: A Model for the Effects of Polycystic Ovarian Disease on the Skeleton?Osteoporosis International, 2000
- Estrogen with interrupted progestin HRT: a review of experimental and clinical studiesMaturitas, 2000
- Historical prospective cohort study of the recurrence of pain after discontinuation of treatment with danazol or a gonadotropin- releasing hormone agonistFertility and Sterility, 1998
- GnRH agonists and add-back therapy: is there a perfect combination?BJOG: An International Journal of Obstetrics and Gynaecology, 1998
- Spontaneous reversibility of bone loss induced by gonadotropin-releasing hormone analog treatmentFertility and Sterility, 1996
- The effect of three hormone replacement regimens on bone density in the aged ovariectomized ratFertility and Sterility, 1995
- Prevalence and genesis of endometriosisHuman Reproduction, 1991
- Gonadotropin-releasing hormone agonists and estrogen-progestogen replacement therapyAmerican Journal of Obstetrics and Gynecology, 1990